chr2-12718368-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_021643.4(TRIB2):āc.61A>Gā(p.Thr21Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T21S) has been classified as Uncertain significance.
Frequency
Consequence
NM_021643.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRIB2 | NM_021643.4 | c.61A>G | p.Thr21Ala | missense_variant | 1/3 | ENST00000155926.9 | |
TRIB2 | NR_027303.2 | n.75+1358A>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRIB2 | ENST00000155926.9 | c.61A>G | p.Thr21Ala | missense_variant | 1/3 | 1 | NM_021643.4 | P1 | |
TRIB2 | ENST00000405331.3 | c.61A>G | p.Thr21Ala | missense_variant | 1/3 | 2 | |||
TRIB2 | ENST00000381465.2 | c.-139+1358A>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151840Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000954 AC: 24AN: 251458Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135918
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727248
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151958Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74284
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.61A>G (p.T21A) alteration is located in exon 1 (coding exon 1) of the TRIB2 gene. This alteration results from a A to G substitution at nucleotide position 61, causing the threonine (T) at amino acid position 21 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at